-
GAVI alliance offers matched funds for GSK malaria vaccine pilot
The GAVI global vaccine alliance has offered funding of up to $27.5 million for pilot tests of GlaxoSmithKline's first-generation malaria vaccine, but only if other organizations promise to match that commitment.
- Categories
- Health Care
- Region
- Europe & Eurasia
-
Weekly Roundup: How Brexit Could Impact Emerging Markets + Other Non-Brexit News
We could not call this a Weekly Roundup without addressing Britain’s decision to leave the European Union (spoiler alert: like most economists, we're struggling to see any upside.) But for those readers who've had their fill of Brexit news, we have plenty more developments to share, including Capria Accelerator's new $100 million fund, Waste Ventures' tie up with Coke, and the dark side to alternative credit scoring.
- Categories
- Health Care, Investing, Social Enterprise
-
IISC Innovation All Set To Make Diabetic Healthcare Afforable
While lifestyle changes and regular monitoring of blood glucose levels could reduce life-threatening complications arising from diabetes, glucometer to detect blood-glucose levels are currently expensive and unaffordable for many. Now scientists at the Indian Institute of Science (IISc), Bengaluru, have developed a low-cost glucometer kit to check blood-glucose levels.
- Categories
- Health Care
- Region
- South Asia
-
A Quick, Simple Malaria Test, and Why It Matters
What problems does a noninvasive, simple test for malaria solve? According to Fyodor, the makers of just such a test which retails for about $2, it can help curb the issues of inappropriate treatment, over-treatment, self-medication or presumptive treatment.
- Categories
- Health Care
-
Patient views highlight potential for Peek smartphone suite to transform eye health
An estimated 285 million people worldwide are visually impaired, of whom 39 million are blind. Up to 80% of blindness and visual impairment is avoidable but a lack of trained specialists and the high cost of buying and transporting the right equipment is a major challenge. This is especially true in rural areas and in the low-income nations of Africa and Asia that share the largest proportion of the burden.
- Categories
- Health Care, Technology
- Region
- Sub-Saharan Africa
-
Scientists announce important Zika milestone: First vaccine ready for human trials
Pennsylvania vaccine maker Inovio Pharmaceuticals and South Korea’s GeneOne Life Sciences said Monday that they had received approval from U.S. regulators to start testing a DNA vaccine, known as GLS-5700, on humans.
- Categories
- Health Care
-
This company wants to provide clean water, using a plastic bag
Providing clean water to their people is a challenge for developing countries struggling to avert health scares while keeping a lid on costs. Three classmates from Singapore are trying to lend a helping hand, using little more than a plastic bag and a ceramic membrane.
- Categories
- Health Care
- Region
- Asia Pacific
-
To fight superbugs, a Harvard chemist invents a new way of making antibiotics
ANTIBIOTICS — the miracle drugs of the 20th century — are beginning to fail. The latest evidence of this came in May, when a pathogen surfaced in Pennsylvania containing a gene that, if and when it spreads, would create bacteria that are invulnerable to every available drug.
- Categories
- Health Care
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.